# Mass Balance Study of TS-142 in Healthy Adult Subjects.

> **NCT04814771** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** [14C] TS-142

## Key facts

- **NCT ID:** NCT04814771
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2021-05-19
- **Final completion:** 2021-05-19
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814771, "Mass Balance Study of TS-142 in Healthy Adult Subjects.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04814771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*